CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill Foundayo
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…
18. Thyme Care
Founders: Robin Shah (CEO), Bobby GreenLaunched: 2020Headquarters: Nashville, TennesseeFunding: $235 millionValuation: N/AKey Technologies: N/AIndustry: HealthcarePrevious appearances on Disruptor…
Stock market today: Live updates
Traders work on the floor of the New York Stock Exchange on April 30, 2026. NYSE Stocks rose…
CVS Health (CVS) earnings Q1 2026
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24,…
UnitedHealth, Cigna, Humana earnings show insurers are recovering
Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to…
Stitch Fix, apparel retailers may benefit
Michelle Suter has worn mostly big and baggy clothing for years. The 63-year-old retiree who lives in a…
Trump administration finalizes Medicare Advantage payment rate
Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz speaks during an event sponsored by the…
Tuesday's big stock stories: What's likely to move the market in the next trading session – CNBC
Tuesday’s big stock stories: What’s likely to move the market in the next trading session CNBCJim Cramer Notes That…
Jobs report March 2026:
The U.S. labor market bounced back in March, with job creation much stronger than expected though the broader…
5 things to know before the market opens Thursday
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Thursday. It’s the one-year…
Novo Nordisk launches Wegovy subscription for GLP-1 obesity drugs
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a…
CVS Health MinuteClinic Services Expand Access to Affordable Primary Care Across US in 2026
CVS Health’s MinuteClinic network continues to grow, offering walk-in primary care, vaccinations, and chronic disease management at over…